Skip to main content
  • Book
  • © 2017

Molecular Targeted Therapy of Lung Cancer

Editors:

(view affiliations)
  • Discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions

  • Describes the increasing necessity for new diagnostic technology and strategies for managing various adverse effects and novel methods for evaluating effectiveness and safety

  • Provides a comprehensive overview, which will provide the foundation for new ideas for further advances

Buying options

eBook
USD 139.00
Price excludes VAT (USA)
  • ISBN: 978-981-10-2002-5
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD 179.99
Price excludes VAT (USA)
Hardcover Book
USD 179.99
Price excludes VAT (USA)

This is a preview of subscription content, access via your institution.

Table of contents (20 chapters)

  1. Front Matter

    Pages i-x
  2. Diagnosis

    1. Front Matter

      Pages 1-1
    2. Classification of Adenocarcinoma of the Lung, with a Special Reference to Prognosis

      • Yukio Nakatani, Yoko Yonemori, Jun Matsushima, Takuya Yazawa
      Pages 3-28
    3. Methods in Molecular Diagnosis

      • Koichi Hagiwara
      Pages 63-77
    4. Next-Generation Sequencing and Bioinformatics

      • Reika Kawabata-Iwakawa, Hidemasa Bono, Masahiko Nishiyama
      Pages 97-115
    5. Companion Diagnostics

      • Emi Noguchi
      Pages 117-136
  3. Treatment

    1. Front Matter

      Pages 137-137
    2. EGFR Mutant

      • Kunihiko Kobayashi, Hiroshi Kagamu
      Pages 167-189
    3. ALK Mutant

      • Akihiko Gemma
      Pages 191-197
    4. Minor-Driver Mutant

      • Akihiko Miyanaga
      Pages 199-212
    5. Immunotherapy

      • Takahiro Ebata
      Pages 227-237
  4. Evaluation

    1. Front Matter

      Pages 269-269

About this book

This book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dramatic effectiveness of molecular targeted therapy, recurrence of the disease, overcoming the wide variety of resistance mechanisms using new-generation molecular targeted agents and potential novel approaches. It also outlines the increasing necessity for new diagnostic technology and strategies for managing different adverse effects and novel methods for evaluating effectiveness and safety. 
Edited and authored by opinion leaders, Molecular Targeted Therapy of Lung Cancer provides a comprehensive overview of the disease and its treatments. It is a valuable resource for graduate students, post-doctoral fellows and faculty staff, as well as researchers involved in clinical and translational research on lung cancer, helping promote new ideas for further advances.

Keywords

  • Angiogenesis
  • Cancer Stem Cell
  • Epithelial-Mesenchymal Transition
  • Immunotherapy
  • Interstitial Lung Diseases
  • Metastasis
  • Molecular Marker
  • Molecular Targeted Therapy
  • Quality of Life
  • Screening
  • Small cell lung cance
  • non-small cell lung cancer

Editors and Affiliations

  • Department of Medical Oncology Graduate School of Medicine, Chiba University, Chiba, Japan

    Yuichi Takiguchi

About the editor

Professor Yuichi Takiguchi
Department of Medical Oncology, Chiba University Graduate School of Medicine

Bibliographic Information

  • Book Title: Molecular Targeted Therapy of Lung Cancer

  • Editors: Yuichi Takiguchi

  • DOI: https://doi.org/10.1007/978-981-10-2002-5

  • Publisher: Springer Singapore

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Science+Business Media Singapore 2017

  • Hardcover ISBN: 978-981-10-2000-1

  • Softcover ISBN: 978-981-10-9500-9

  • eBook ISBN: 978-981-10-2002-5

  • Edition Number: 1

  • Number of Pages: X, 327

  • Number of Illustrations: 6 b/w illustrations, 48 illustrations in colour

  • Topics: Pneumology, Oncology, Biomedical Research

  • Industry Sectors: Biotechnology, Health & Hospitals, Pharma

Buying options

eBook
USD 139.00
Price excludes VAT (USA)
  • ISBN: 978-981-10-2002-5
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD 179.99
Price excludes VAT (USA)
Hardcover Book
USD 179.99
Price excludes VAT (USA)